CN101439058A - 一种复方银杏的中药颗粒及其制备方法 - Google Patents
一种复方银杏的中药颗粒及其制备方法 Download PDFInfo
- Publication number
- CN101439058A CN101439058A CNA2007101503243A CN200710150324A CN101439058A CN 101439058 A CN101439058 A CN 101439058A CN A2007101503243 A CNA2007101503243 A CN A2007101503243A CN 200710150324 A CN200710150324 A CN 200710150324A CN 101439058 A CN101439058 A CN 101439058A
- Authority
- CN
- China
- Prior art keywords
- master batch
- slurry
- active component
- present
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 94
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 150000001875 compounds Chemical class 0.000 title claims abstract description 36
- 239000008187 granular material Substances 0.000 title claims description 87
- 244000194101 Ginkgo biloba Species 0.000 title abstract description 47
- 239000002245 particle Substances 0.000 claims abstract description 144
- 239000000284 extract Substances 0.000 claims abstract description 70
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 53
- 239000003937 drug carrier Substances 0.000 claims abstract description 14
- 239000007921 spray Substances 0.000 claims description 151
- 239000002002 slurry Substances 0.000 claims description 135
- 239000004594 Masterbatch (MB) Substances 0.000 claims description 128
- 239000000203 mixture Substances 0.000 claims description 103
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 70
- 239000012530 fluid Substances 0.000 claims description 58
- 238000000034 method Methods 0.000 claims description 58
- 229920002472 Starch Polymers 0.000 claims description 57
- 239000008107 starch Substances 0.000 claims description 57
- 235000019698 starch Nutrition 0.000 claims description 57
- 235000011201 Ginkgo Nutrition 0.000 claims description 51
- 229920001353 Dextrin Polymers 0.000 claims description 49
- 239000004375 Dextrin Substances 0.000 claims description 49
- 238000000576 coating method Methods 0.000 claims description 49
- 235000019425 dextrin Nutrition 0.000 claims description 49
- 239000011248 coating agent Substances 0.000 claims description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- 239000000463 material Substances 0.000 claims description 47
- 239000000843 powder Substances 0.000 claims description 40
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 38
- 229920003081 Povidone K 30 Polymers 0.000 claims description 38
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 36
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 36
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 36
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 36
- 239000003795 chemical substances by application Substances 0.000 claims description 31
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 30
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 30
- 235000020710 ginseng extract Nutrition 0.000 claims description 29
- 239000000341 volatile oil Substances 0.000 claims description 28
- 238000010410 dusting Methods 0.000 claims description 27
- 229960004756 ethanol Drugs 0.000 claims description 27
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 25
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims description 25
- 239000000741 silica gel Substances 0.000 claims description 25
- 229910002027 silica gel Inorganic materials 0.000 claims description 25
- 239000007787 solid Substances 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 16
- 241000208340 Araliaceae Species 0.000 claims description 15
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 15
- 229930195725 Mannitol Natural products 0.000 claims description 15
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 15
- 235000008434 ginseng Nutrition 0.000 claims description 15
- 239000000594 mannitol Substances 0.000 claims description 15
- 235000010355 mannitol Nutrition 0.000 claims description 15
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 14
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 14
- 238000012546 transfer Methods 0.000 claims description 14
- 229920001661 Chitosan Polymers 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 12
- 238000000638 solvent extraction Methods 0.000 claims description 12
- 238000001179 sorption measurement Methods 0.000 claims description 12
- 238000003809 water extraction Methods 0.000 claims description 12
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims description 11
- 239000002202 Polyethylene glycol Substances 0.000 claims description 10
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 10
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 10
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 9
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 9
- 239000001341 hydroxy propyl starch Substances 0.000 claims description 9
- 235000013828 hydroxypropyl starch Nutrition 0.000 claims description 9
- 239000008101 lactose Substances 0.000 claims description 9
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 9
- 239000011734 sodium Substances 0.000 claims description 9
- 239000000811 xylitol Substances 0.000 claims description 9
- 235000010447 xylitol Nutrition 0.000 claims description 9
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 9
- 229960002675 xylitol Drugs 0.000 claims description 9
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 7
- 239000011347 resin Substances 0.000 claims description 7
- 229920005989 resin Polymers 0.000 claims description 7
- 239000003981 vehicle Substances 0.000 claims description 5
- 229930003944 flavone Natural products 0.000 claims description 4
- 235000011949 flavones Nutrition 0.000 claims description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- 235000019441 ethanol Nutrition 0.000 claims description 2
- 150000002212 flavone derivatives Chemical class 0.000 claims description 2
- 150000002596 lactones Chemical class 0.000 claims description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 2
- 229930182490 saponin Natural products 0.000 claims description 2
- 150000007949 saponins Chemical class 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 2
- 241000218628 Ginkgo Species 0.000 claims 9
- 239000002775 capsule Substances 0.000 abstract description 15
- 239000003405 delayed action preparation Substances 0.000 abstract description 5
- 239000011265 semifinished product Substances 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 26
- 238000005516 engineering process Methods 0.000 description 14
- 239000007788 liquid Substances 0.000 description 11
- 229940079593 drug Drugs 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 6
- 239000011230 binding agent Substances 0.000 description 6
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 6
- 239000003085 diluting agent Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000003643 water by type Substances 0.000 description 5
- 210000000589 cicatrix Anatomy 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000007767 bonding agent Substances 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- -1 terpene lactones Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000011868 grain product Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000005563 spheronization Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101503243A CN101439058B (zh) | 2007-11-22 | 2007-11-22 | 一种复方银杏的中药颗粒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101503243A CN101439058B (zh) | 2007-11-22 | 2007-11-22 | 一种复方银杏的中药颗粒及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101439058A true CN101439058A (zh) | 2009-05-27 |
CN101439058B CN101439058B (zh) | 2011-10-05 |
Family
ID=40723756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101503243A Expired - Fee Related CN101439058B (zh) | 2007-11-22 | 2007-11-22 | 一种复方银杏的中药颗粒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101439058B (zh) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100342859C (zh) * | 2004-08-20 | 2007-10-17 | 中国人民解放军军事医学科学院毒物药物研究所 | 含巴戟天提取物的制剂的制备方法 |
CN1872111B (zh) * | 2005-06-01 | 2010-09-29 | 天津天士力制药股份有限公司 | 一种治疗心脑血管疾病的药物 |
-
2007
- 2007-11-22 CN CN2007101503243A patent/CN101439058B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101439058B (zh) | 2011-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101472565B (zh) | 颗粒剂的制备方法 | |
CN101439076B (zh) | 一种含降香油的中药颗粒的制备方法 | |
CN101439057B (zh) | 一种含银杏提取物的中药颗粒及其制备方法 | |
CN101439135B (zh) | 一种含石菖蒲提取物的中药颗粒及其制备方法 | |
CN101439065B (zh) | 一种含三七提取物的中药颗粒及其制备方法 | |
CN101439067B (zh) | 一种含人参提取物的中药颗粒及其制备方法 | |
CN101439062B (zh) | 一种含穿心莲内酯的中药颗粒及其制备方法 | |
CN101439107B (zh) | 一种含山楂提取物的中药颗粒及其制备方法 | |
CN101439063B (zh) | 一种含当归提取物的中药颗粒剂及其制备方法 | |
CN101439066B (zh) | 一种含三七提取物的中药颗粒及其制备方法 | |
CN101439058B (zh) | 一种复方银杏的中药颗粒及其制备方法 | |
CN101439087B (zh) | 一种含丹参提取物的中药颗粒及其制备方法 | |
CN101439084B (zh) | 一种含藿香提取物的中药颗粒及其制备方法 | |
CN101439082B (zh) | 一种含苦参提取物的中药颗粒及其制备方法 | |
CN101439041B (zh) | 一种含灯盏花素的中药颗粒及其制备方法 | |
CN101439086B (zh) | 一种含丹参总酚酸的中药颗粒及其制备方法 | |
CN101439068B (zh) | 一种含水飞蓟素的中药颗粒及其制备方法 | |
CN101439078B (zh) | 一种含黄芪提取物的中药颗粒及其制备方法 | |
CN101439126B (zh) | 一种含黄杨宁的中药颗粒及其制备方法 | |
CN101439099B (zh) | 一种含赤芍提取物的中药颗粒及其制备方法 | |
CN101439079B (zh) | 一种含黄芪总皂甙的中药颗粒的制备方法 | |
CN101439122B (zh) | 一种含熟地黄提取物的中药颗粒及其制备方法 | |
CN101439143B (zh) | 一种含知母提取物的中药颗粒及其制备方法 | |
CN101439085B (zh) | 含藿香提取物的中药颗粒及其制备方法 | |
CN101439105A (zh) | 一种含酸枣仁提取物的中药颗粒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee before: Tasly Pharmaceutical Group Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111005 Termination date: 20201122 |
|
CF01 | Termination of patent right due to non-payment of annual fee |